Author:
Lindemalm Synnöve,Liliemark Jan,Larsson Bengt S,Albertioni Freidoun
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy,Cancer Research,Oncology
Reference30 articles.
1. Bryson HM, Sorkin EM. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies [Review].Drugs 1993;46: 872–894.
2. Montgomery J, Shortnacy-Flower A, Clayton Set al. Synthesis and biological activity of 2′-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.J Med Chem 1992;35: 397–401.
3. Parker W, Shaddix S, Chang Cet al. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polumerases by its 5′-triphosphate.Cancer Res 1991;51: 2386–2394.
4. Takahashi T, Kanazawa J, Akinaga Set al. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.Cancer Chemother Pharmacol 1999;43: 233–240.
5. Carson D, Wasson B, Esparza Let al. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabinofluoro-2′-deoxyadenosine.Proc Natl Acad Sci USA 1992;89: 2970–2974.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献